cell width large
METPO:1000890 · CLASS · REVIEWED
A cell-width phenotype in which the shorter cell dimension exceeds approximately 0.9 micrometers.
Large cell-width by elevated wall-radius set-point
Edge evidence
-
rich growth conditions
shifts
Rod-complex peptidoglycan synthesis
Rich growth conditions shift Rod-complex activity toward a larger radius set-point.
-
DOI:10.1126/science.aaa1313cell size scales with growth rate
-
-
Rod-complex peptidoglycan synthesis
confers
cell width large
METPO:2007700Elevated Rod-complex activity yields a wide rod radius.
-
DOI:10.1146/annurev-cellbio-101011-155745MreB-directed peptidoglycan synthesis
-
-
cell width large
is a
cell width
rdfs:subClassOfLarge cell width is a quantitative bin of the cell-width phenotype.
-
DOI:10.1146/annurev-cellbio-101011-155745MreB-directed peptidoglycan synthesis
-
-
RodA-PBP2 allosteric activation
positively regulates
peptidoglycan polymerization and crosslinking
RO:0002213Allosteric structural opening of RodA-PBP2 activates coupled PG polymerization and crosslinking.
-
DOI:10.1038/s41467-023-39037-9
-
-
RodA-PBP2 elongasome complex
mediates
lateral sidewall peptidoglycan insertion
Activated RodA-PBP2 elongasome synthesizes and inserts new PG at lateral wall sites.
-
DOI:10.1073/pnas.2215237120
-
-
lateral sidewall peptidoglycan insertion
contributes to
Rod-complex peptidoglycan synthesis
RO:0002326Lateral sidewall PG insertion is the Rod-complex-driven wall-elongation process that sets rod radius.
-
DOI:10.1146/annurev-cellbio-101011-155745
-
-
MreB cytoskeletal filaments
orients
circumferential peptidoglycan insertion
MreB filaments orient peptidoglycan insertion perpendicular to the long cell axis, controlling rod radius.
-
DOI:10.1073/pnas.2301987120
-
-
Rod-complex circumferential rotation
enables
even peptidoglycan distribution
RO:0002327Rotation of the Rod complex around the circumference enables evenly distributed PG insertion.
-
DOI:10.1002/mbo3.1385
-
-
MreC-MreD balance
regulates
PBP2 transpeptidase activity
RO:0002211The balance between MreC and MreD determines PBP2 synthase activity.
-
DOI:10.1002/mbo3.1385
-
-
Lipid II
required for
peptidoglycan polymerization and crosslinking
Lipid II is the substrate required for peptidoglycan polymerization by Rod/elongasome synthases.
-
DOI:10.3390/biom13050720
-
Provenance
- Source
- METPO (2025-11-25)
- Definition source
- DOI:10.1146/annurev-cellbio-101011-155745
Parent traits (1)
Synonyms (1)
- W_>0.9
kg-microbe context
Matched 1 kg-microbe node via direct_metpo.
METPO:1000890[+0.641, -3.918, -1.937, +4.002, …]
Nearest neighbors in embedding space
- environment pH range mid1 0.572
- environment temperature range mid1 0.557
- environment temperature range low 0.546
- environment pH range mid2 0.541
- morphology cell length medium 0.540
- environment temperature range very low 0.536
- environment pH range mid3 0.531
- environment pH range low 0.525
Deep research
# Curation-focused research report: **cell width large** ## 1. Trait scope **Trait:** “cell width large” **Identifier:** `METPO:1000890` **Category:** morphology; **term kind:** class; **mapping:** reviewed **Operational definition:** the shorter dimension of a microbial cell exceeds approximately **0.9 μm**. This is best treated as an **assay-observed morphological state**, not as a pathway or intrinsic taxonomic property. For rods, width should be measured perpendicular to the longitudinal axis, preferably from segmented, exponentially growing single cells under specified medium, temperature, osmolarity, and imaging conditions. A population should instantiate the class only when its representative statistic—ideally median or mean single-cell width—crosses the threshold, rather than merely containing occasional cells wider than 0.9 μm. ### Boundary cases * **Increased length or volume without increased short-axis dimension** is not `METPO:1000890`. * **Filamentation** caused by division inhibition is primarily a length phenotype unless width also exceeds 0.9 μm. * **Local bulges, branches, or septal swelling** are evidence of width dysregulation but do not establish a whole-cell large-width phenotype without a defined measurement rule. * **Rod-to-sphere conversion** often entails widening, but “spherical,” “rounded,” or “increased volume” should not automatically be mapped to `METPO:1000890`; an actual short-axis measurement is required. * **Transient osmotic swelling, L-forms, protoplasts, and wall-less cells** should be modeled separately unless the intended graph explicitly covers these assay states. * The 0.9-μm boundary is not universal biological evidence of abnormality: naturally broad or giant taxa may exceed it as their normal morphology. The strongest current model is that width emerges from the **relative activities and spatial organization of peptidoglycan synthesis/remodeling systems**, rather than from MreB abundance or growth rate alone. In *Bacillus subtilis*, circumferential Rod-system synthesis narrows cells, whereas class-A penicillin-binding proteins tend to widen them; directional MreB/Rod-complex density, not a unique MreB filament geometry, predicts diameter across perturbations (dion2018celldiameterin pages 3-6, dion2018celldiameterin pages 18-19, dion2018celldiameterin pages 8-10, dion2018celldiameterin pages 1-3). ## 2. Candidate graph nodes ### Phenotypes and processes * **cell width large** — `METPO:1000890` * regulation of cell shape — candidate `GO:0008360` * peptidoglycan-based cell wall — candidate `GO:0009274` * cell-wall/peptidoglycan biosynthesis * circumferential peptidoglycan insertion * directional Rod-complex motion * peptidoglycan mechanical anisotropy * isotropic peptidoglycan insertion * peptidoglycan hydrolysis/endopeptidase activity * local cell widening and bulging * spherical-cell or rounding phenotype — retain as a separate phenotype node unless width is measured * outer-membrane load-bearing capacity ### Proteins and complexes * **Rod complex/elongasome** — complex node containing taxon-dependent components * **MreB**, plus *B. subtilis* homologues Mbl and MreBH * **RodA** — SEDS-family peptidoglycan glycosyltransferase * **PBP2/MrdA** in *E. coli*; **PBP2A/PbpH** in *B. subtilis* — class-B transpeptidases * **MreC**, **MreD**, **RodZ** — accessory/activation and coupling components * **class-A PBPs**, especially PBP1/PonA in *B. subtilis* * peptidoglycan DL- and DD-endopeptidases * **PBP5/DacA**, CwlO, FtsE, FtsX — width-related candidates from the *B. subtilis* screen * metabolic candidates: Rpe, Pyk, PtsH, GuaA, PanD * MinJ, YaaA, YbzH — secondary candidates requiring gene-specific mechanistic follow-up Protein nodes should be assigned **taxon-specific UniProt accessions during implementation**. A generic “MreB” node is useful for a high-level graph, but it should not be given a single species-specific accession across *E. coli*, *B. subtilis*, and other taxa. ### Chemicals and environmental/experimental factors * **magnesium(2+)** — candidate `CHEBI:18420` * **A22** — MreB-polymerization antagonist; retain label-only until its exact ChEBI record is verified * **mecillinam/amdinocillin** — PBP2-directed β-lactam; verify the chemical CURIE before curation * nutrient-rich versus minimal medium
Curation history
-
·
SEEDED_FROM_METPO · seed_from_metpo
imported from data/raw/metpo.owl (CLASS)
-
·
CURATED_CAUSAL_GRAPH · claude
Added DOI-backed causal graph linking rich growth conditions and elevated Rod-complex activity to large cell width (>0.9 μm).
-
·
GROUND_CAUSAL_PREDICATES · claude
Grounded 2 causal-edge predicate_id field(s) via mappings/predicate_grounding.tsv (METPO:2000202×1, rdfs:subClassOf×1).
-
·
ENRICH_CAUSAL_GRAPH · claude
Added 7 evidence-backed generic edges (11 new nodes) from the deep-research report.
-
·
GROUND_CAUSAL_PREDICATES · claude
Grounded 3 causal-edge predicate_id field(s) via mappings/predicate_grounding.tsv (RO:0002326×1, RO:0002327×1, RO:0002211×1).
-
·
GROUND_CAUSAL_NODES · claude
Grounded 1 causal-node grounding field(s) via mappings/node_grounding.tsv (CHEBI:27692×1).
-
·
GROUND_CAUSAL_PREDICATES · claude
Grounded 1 causal-edge predicate_id field(s) via mappings/predicate_grounding.tsv (RO:0002213×1).
-
·
MIGRATE_MICROBE_DOMAIN_EDGES · claude
Re-grounded 1 causal edge(s) off microbe-domain METPO predicates (1 to confers), issue 301. The previous predicates are transitively rdfs:subPropertyOf METPO:2000001, whose rdfs:domain is METPO:1000525 (microbe), so a causal-graph subject entailed that the subject IS a microbe; CausalNodeTypeEnum has no organism member, so no such edge could ever satisfy the domain. Edge directions are unchanged - this pass only relabels and re-grounds. RO:0002234 (has output) is used where the subject is an activity, since biolink gives it the domain 'biological process or activity'; the METPO replacements are proposed in proposals/metpo_traitmech_v8 and v9 and are placeholder ids until METPO mints them.
-
·
REGROUND_CAUSAL_EDGE · claude
Edge rod_complex_rotation -> even_pg_distribution in graph cell_width_large_setpoint_increase: retyped even_pg_distribution to BIOLOGICAL_PROCESS. Issue 334. biolink declares enables range 'biological process or activity', which of CausalNodeTypeEnum only BIOLOGICAL_PROCESS, PATHWAY and MOLECULAR_FUNCTION satisfy, so this edge entailed a false type on its object. The label reads like a quality but the description does not: 'Evenly distributed INSERTION of peptidoglycan in the cell-surface layer.' Insertion is a process, so `enables` is already the right relation and only the node type was wrong.